Phosphoric Acid

Phosphoric Acid

SCHEMBL1823985

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ge+4].[Ge+4].[Ge+4]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.46
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL524871 1.00
Phosphoric Acid SCHEMBL30991428 0.94
Phosphoric Acid SCHEMBL31744457 0.94
Phosphoric Acid SCHEMBL28369682 0.94
Phosphoric Acid SCHEMBL4413664 0.94 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL952101 0.94 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL10945030 0.94
Phosphoric Acid SCHEMBL361690 0.94 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL11433866 0.94
Phosphoric Acid SCHEMBL28617225 0.94 SLC34A1 (0.42) SLC34A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260142188-A1 ANODE MATERIAL AND BATTERY BTR NEW MATERIAL GROUP CO., LTD. (CN) 2026-05-21 US claimed
EP-4648131-A2 MATRIX, ANODE MATERIAL, AND SECONDARY BATTERY BTR New Material Group Co., Ltd. (CN) 2025-11-12 EP claimed
US-20250333310-A1 MATRIX, ANODE MATERIAL, AND SECONDARY BATTERY BTR NEW MATERIAL GROUP CO., LTD. (CN) 2025-10-30 US claimed
EP-4589680-A2 ANODE MATERIAL, ANODE SHEET, AND SECONDARY BATTERY BTR New Material Group Co., Ltd. (CN) 2025-07-23 EP claimed
US-20250046797-A1 Coated Single Crystalline Metal Oxide Materials and Method for Producing The Same Action Battery Technologies, Inc. 2025-02-06 US claimed
CN-119108525-A Negative electrode material, negative electrode sheet, and secondary battery 贝特瑞新材料集团股份有限公司 2024-12-10 CN claimed
CN-119092693-A Matrix, negative electrode material, and secondary battery 贝特瑞新材料集团股份有限公司 2024-12-06 CN claimed
CN-119092692-A Negative electrode material, negative electrode sheet, and secondary battery 贝特瑞新材料集团股份有限公司 2024-12-06 CN claimed
CN-119050328-A Negative electrode material, negative electrode plate and battery 贝特瑞新材料集团股份有限公司 2024-11-29 CN claimed
CN-118507703-A Negative electrode material and battery 贝特瑞新材料集团股份有限公司 2024-08-16 CN claimed
EP-2786440-B1 REACTIVE SINTERING OF CERAMIC LITHIUM-ION SOLID ELECTROLYTES CORNING INC (US) 2019-06-12 EP claimed
EP-3455892-A1 SOLID ELECTROLYTE SEPARATOR BONDING AGENT QuantumScape Corporation (US) 2019-03-20 EP claimed
US-9673483-B2 Reactive sintering of ceramic lithium ion electrolyte membranes CORNING INCORPORATED (US) 2017-06-06 US claimed
US-20160211546-A1 REACTIVE SINTERING OF CERAMIC LITHIUM ION ELECTROLYTE MEMBRANES ENERGY, UNITED STATES DEPARTMENT OF 2016-07-21 US claimed
CN-104193141-A Method for preparing Bi-doped glass material with mid-infrared luminescence UNIV ZHEJIANG 2014-12-10 CN claimed
EP-2786440-A1 REACTIVE SINTERING OF CERAMIC LITHIUM-ION SOLID ELECTROLYTES Corning Incorporated (US) 2014-10-08 EP claimed
CN-103708735-A Method for raising near infrared light emitting thermal stability of Bi-doped glass UNIV ZHEJIANG 2014-04-09 CN claimed
WO-2013082231-A1 REACTIVE SINTERING OF CERAMIC LITHIUM-ION SOLID ELECTROLYTES CORNING INCORPORATED (US) 2013-06-06 WO claimed
US-20130137010-A1 REACTIVE SINTERING OF CERAMIC LITHIUM-ION SOLID ELECTROLYTES CORNING INCORPORATED 2013-05-30 US claimed
US-5200378-A Nonswelling in water; layers of group IV A OR IV B phosphate, alkali titanate, titanium niobate, etc., pillaring substance from cationic hydroxy metal complexes THE TEXAS A&M UNIVERSITY SYSTEM (US) 1993-04-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260142188-A1 ANODE MATERIAL AND BATTERY CACNA2D4, CACNA2D1, CACNA2D2 SLC34A1 898/4885LMNA 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.